If you've been researching weight loss medications, you've likely come across two names again and again: semaglutide and tirzepatide. Both are injectable GLP-1 receptor agonists that can help you lose weight and improve metabolic health. But which one is better? The short answer is: it depends. Let's break down the differences in plain language, so you can have a more informed conversation with your healthcare provider.

How They Work

Semaglutide (the active ingredient in Ozempic and Wegovy) targets a single hormone pathway called GLP-1. It helps reduce appetite, slow stomach emptying, and increase insulin secretion when blood sugar is high. It's been around longer and has a lot of clinical evidence behind it.

Tirzepatide (the active ingredient in Mounjaro and Zepbound) is a dual-acting medication—it stimulates both GLP-1 and GIP receptors. GIP is another incretin hormone that may enhance the weight loss effect. Early studies suggest tirzepatide may lead to greater average weight loss than semaglutide, but that doesn't necessarily mean it's the right choice for everyone.

Effectiveness: What the Numbers Say

In clinical trials, people taking tirzepatide lost more weight on average than those taking semaglutide. For example, one study showed that after 72 weeks, people on tirzepatide lost up to 20% of their body weight, while those on semaglutide lost about 15%. However, these are averages—individual results can vary widely.

  • Semaglutide: typically leads to 10–15% total body weight loss over a year.
  • Tirzepatide: often leads to 15–20% total body weight loss over a year.

Keep in mind that both medications are most effective when paired with a reduced-calorie diet and increased physical activity. They are tools, not magic bullets.

Side Effects and Tolerability

Both medications can cause gastrointestinal side effects, especially when you first start them or increase the dose. Common issues include nausea, vomiting, diarrhea, constipation, and abdominal pain. These often improve over time, but for some people they can be severe enough to stop treatment.

Some research suggests that tirzepatide may cause slightly fewer gastrointestinal side effects than semaglutide, but that's not a guarantee for every person. Your own tolerance will depend on your unique body and how quickly your dose is adjusted. It's important to start at a low dose and work up slowly under medical supervision.

Also, note that these medications carry a boxed warning about a rare risk of thyroid C-cell tumors, which was observed in animal studies. They should not be used in people with a personal or family history of medullary thyroid carcinoma or MEN-2 syndrome.

Ready to discuss your options?
Medcare Telehealth offers affordable, membership-based remote consultations with board-certified NPs in NY and FL. For just $29/month (individual) or $49/month (family plan, 4 visits), you can talk to a provider about weight management—no insurance required. Sign up today to get started.

Cost and Availability

Both medications are brand-name drugs, so cost can be a significant factor. Your total out-of-pocket will depend on your insurance coverage, if any, and whether you're using a manufacturer savings card. Generally, tirzepatide tends to be more expensive than semaglutide, though prices can vary by pharmacy. For many people, cost is the deciding factor.

Availability has also been an issue for both drugs due to high demand. However, compounding pharmacies may offer more affordable alternatives, but these are not FDA-approved and require careful consideration. Always check that your compounded medication comes from a licensed pharmacy—our NPs can discuss what to look for.

Which One Should You Choose?

There isn't a universal "better"—it's about what fits your health profile, budget, and comfort level. If you're looking for a well-established medication with a long track record, semaglutide might be a good fit. If you want the potential for greater weight loss and can tolerate a newer drug, tirzepatide could be worth discussing. Your medical history—especially any history of thyroid cancer, pancreatitis, or kidney issues—will also play a role.

Your NP will consider all of these factors and help you make a personalized decision. They'll also talk about lifestyle changes, realistic expectations, and monitoring plans.

Before You Start

Before your video visit, have a list of your current medications, any allergies, and your medical history (including any miscarriages or family history of thyroid cancer) ready. Be honest about your weight loss efforts and what you've tried before.

Also, remember: if you experience chest pain, severe abdominal pain, difficulty breathing, or any signs of an allergic reaction, don't wait for an appointment—call 911 or go to your nearest emergency room. This blog is informational and not a substitute for professional medical advice.

Ready to talk about whether semaglutide or tirzepatide might be right for you? Book a visit with Medcare Telehealth today—our NPs are licensed in NY and FL and available Monday–Friday, 9 AM–6 PM Eastern. Average wait time to connect is about 10 minutes.